Physician profile
Marcus Sims
NPI 1427199546
$31,691.22
in general payments reported to CMS, 2019-2025
43 companies · $1,632 in 2025
The $1,632 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,460 · 2020: $5,570 · 2021: $5,859 · 2022: $8,439 · 2023: $7,052 · 2024: $1,679 · 2025: $1,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,863 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,863.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22,077.04 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $825.46 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Bodyguardian |
| Astrazeneca Pharmaceuticals Lp | $660.02 | 2019-2025 | Farxiga, Wainua |
| Abiomed | $624.69 | 2019-2025 | Impella |
| Medtronic, INC. | $608.64 | 2023-2025 | Micra, Symplicity G3, Onyx Frontier |
| Edwards Lifesciences Corporation | $523.01 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $506.87 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $496.56 | 2022-2023 | Optimizer |
| Pfizer INC. | $485.71 | 2019-2025 | |
| Amgen INC. | $471.70 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $440.56 | 2022-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $424.00 | 2022-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $354.97 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $340.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.45 | 2022-2025 | Jardiance |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $328.72 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $314.46 | 2020-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $251.76 | 2019-2023 | Cardiomems |
| Esperion Therapeutics, INC. | $244.08 | 2021-2025 | Nexletol |
| Inari Medical, INC. | $192.61 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $132.78 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $128.85 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $113.39 | 2019 | |
| Heartflow, INC. | $112.97 | 2022-2023 | Ffrct |
| Cardiovascular Systems INC. | $95.49 | 2019-2022 | |
| Scpharmaceuticals INC. | $80.51 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $68.45 | 2024 | Arcalyst |
| Chiesi USA, INC. | $50.50 | 2019-2025 | Kengreal |
| Cardiva Medical, INC. | $46.47 | 2019-2024 | Optowire |
| Getinge USA Sales, LLC | $43.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $42.20 | 2019 | |
| Cordis US Corp. | $41.47 | 2025 | Mynx Control Venous, Mynx Control |
| Becton, Dickinson and Company | $39.75 | 2024 | Hemosphere |
| Kowa Pharmaceuticals America, INC. | $28.10 | 2021 | |
| Lilly USA, LLC | $25.52 | 2025 | Zepbound |
| Kiniksa Pharmaceuticals, Ltd. | $22.25 | 2022 | |
| Argon Medical Devices, INC. | $20.67 | 2024 | Clot Management |
| Daiichi Sankyo INC. | $19.28 | 2023 | Injectafer |
| Lundbeck LLC | $17.32 | 2019 | |
| Terumo Medical Corporation | $17.08 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.70 | 2023 | Opsumit, Uptravi |
| Smith+Nephew, INC. | $13.99 | 2023 | Pico 7, Pico 14, Renasys Go V2 Home |
| Arbor Pharmaceuticals, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.